isoflurane
Commercial- Indications
- Anesthesia
Company intelligence / Profile preview
Minrad developed and marketed generic inhalation anesthetics such as isoflurane, enflurane, sevoflurane, and was developing desflurane. The company also produced real-time image guidance devices for minimally invasive surgery. Prior to its acquisition by Piramal Healthcare in 2008, it had a global distribution network supplying hospitals, clinics, research centers, and veterinary facilities[1][2][3][4].
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minrad International, Inc..